{"productName":"Foundayo™","molecule":" (orforglipron)","productLogoUrl":"","warning":true,"warnings":[{"title":"WARNING: RISK OF THYROID C-CELL TUMOR","warning":"• In products with glucagon-like peptide-1 (GLP-1) receptor agonist activity that are pharmacologically active in rats and mice, rodent thyroid C-cell tumors (adenomas and carcinomas) have been observed at clinically relevant exposures and are considered GLP-1 receptor-dependent effects in rodents. Orforglipron is not pharmacologically active in rats or mice and did not produce tumors in rodents. While orforglipron is pharmacologically active at the human GLP-1 receptor, the human relevance of GLP-1 receptor-dependent thyroid C-cell tumors observed in rodents has not been determined.\n\n• Foundayo™ (orforglipron) is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors."}],"user":"HCP","extLinks":"http://www.goodrx.com/,http://www.lowestmed.com/,http://www.rxpricequotes.com/,https://www.tsa.gov/","bubbleBackground":"#F2F2F2","bubbleBorderColor":"#F2f2f2","bubbleFromUserBackground":"#D52B1E","bubbleFromUserBorderColor":"#D52B1E","bubbleFromUserTextColor":"White","bubbleTextColor":"Black","botAvatarBackgroundColor":"#FFFFFF","sessionTimeout":1800,"headerBackgroundColor":"#D52B1E","suggestedButtonsBorder":"2px solid #D52B1E","suggestedButtonBackgroundColor":"#D52B1E","suggestedButtonDefaultBackgroundColor":"","interstitialContinueBackground":"#D52B1E","interstitialContinueBorder":"#D52B1E","interstitialExternalLinkMessage":"","botToken":"eyJhbGciOiJSUzI1NiIsImtpZCI6Ik5jWDdGWWlPd1k2eEc3cEdzbU81eENZZmgzTSIsIng1dCI6Ik5jWDdGWWlPd1k2eEc3cEdzbU81eENZZmgzTSIsInR5cCI6IkpXVCJ9.eyJib3QiOiJkZXYtbG0tY2hhdGJvdC1ib3QiLCJzaXRlIjoiVnVjeVltc3VvR2ciLCJjb252IjoiazV2YUY5eEFZZTZteWtLN0VDMGx2LXVzIiwidXNlciI6ImRsX2ZvdW5kYXlvX2hjcF9mZTQyYmYxZS05ZjU2LTQyZTAtOWVlMi05YTJlYjQ5Y2NmYjkiLCJqdGkiOiI4REYwQTkyOEJGMzAwMEYtMWMxZjJkZmZjNzA2NGI2ZDk5ZGZlNTQ0NmQxZjU3MTUiLCJza2kiOiIxIiwib2F0IjoiMTc4ODUzMjg2MyIsIm5iZiI6MTc4ODUzMjg2MywiZXhwIjoxNzg4NTM2NDYzLCJpc3MiOiJodHRwczovL2RpcmVjdGxpbmUuYm90ZnJhbWV3b3JrLmNvbS8iLCJhdWQiOiJodHRwczovL2RpcmVjdGxpbmUuYm90ZnJhbWV3b3JrLmNvbS8ifQ.oqa9h_4Ohcz6U4rCtA9AcC74OejaK0TmlzcZltCeoPVYcoMCMM4G2Oc1EGW8STMu4kBLFr6NpeRY-9bnjnLA9Qv7a3ppx35IfrhscZgvZmttBdmgJHat2IWjCi0i3e4h6EGTus7cLiYf9gI4CjM__9t04rFtUjtEXCaU7o5CL3c5USuGVnzQdfV4bmNIOr94QyUk9ZBWQOiFueQUFDju-9bJ4MP6l3oukOD3zdBfjbqDVCfguEgiUgs8Z9CSa6RujPvMmHGPJadxdYP2Bj5OUuRYLaaUFCxH2swFPv67bMTa_WsX9KtAw18TfbAvGgD0G4pCvkvBBAaCHjPDElaZaQ","userId":"dl_foundayo_hcp_fe42bf1e-9f56-42e0-9ee2-9a2eb49ccfb9","verticalAlignment":true,"bannerColor":"#D52B1E","secureLinks":"","apiURL":"https://dev.api.assist.lilly.com","headerTextColor":"","headerHeight":"","responseFeedbackText":"Was this content helpful?","logoHeight":"","enableFeedbackThankYou":false,"thumbsUpThankYou":false,"thumbsUpThankYouText":"","starRatingPromptText":"","starRatingThankYouText":"","starRatingLowScoreText":"","starRatingLowScoreFeedbackButtons":[],"starRatingLowScoreFeedbackThankYouText":"","informationPromptText":"","lillyAssistIcon":"","PersistentChatEnabled":false,"idleTimerEnabled":false,"idleTimeoutSeconds":600,"inputBoxStayFocused":false,"trackingId":"f5d37ca7-d0f4-4430-a962-bf3fc171fee2"}